Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 07.11.2024
Relmada Therapeutics Мультипликаторы 2011-2024 | RLMD
Мультипликаторы по годам Relmada Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.6 | -0.5 | -2.9 | -8.6 | -3.1 | -1.8 | -1.6 | -7.5 | -3.5 | -1.8 | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-3.3 | -5.3 | -7.2 | -3.8 | -1.6 | -2.9 | -0.5 | -0.3 | -2.1 | - | -40.9 | -3.2 | - |
EV (Enterprise Value) |
170 млн | 78.5 млн | 331 млн | 520 млн | 20.1 млн | 21.8 млн | 9.45 млн | 17 млн | 65.2 млн | 38.8 млн | -3.49 млн | -1.77 млн | -21.9 тыс. |
EBITDA per Share |
-3.45 | -5.44 | -7.16 | -3.9 | -2.02 | -2.2 | -2.36 | -5.57 | -6.88 | -48 | - | - | - |
EV/EBITDA |
-2.9 | -8.3 | -3.5 | -2.4 | -1.2 | -0.9 | -2.9 | -0.4 | - | - | - | ||
PEG |
-0.08 | -0.02 | -0.14 | 0.02 | -1.1 | 0.05 | 0.02 | -0.09 | -0.05 | 0.02 | - | - | - |
P/B |
1.9 | 0.5 | 1.7 | 4.8 | 7.1 | -2.8 | 6.7 | 3.2 | 8.2 | -33.7 | - | - | - |
P/CF |
-3.1 | -0.7 | -3.9 | -18.3 | -5.1 | -2.6 | -1.5 | -1.6 | -4.4 | -17.3 | - | - | - |
ROE % |
-115.74 | -111.83 | -60.38 | -56.31 | -227.47 | 162.54 | -430.50 | -42.24 | -236.14 | 1922.52 | - | - | - |
ROA % |
-101.27 | -102.71 | -56.31 | -50.31 | -169.46 | -293.98 | -221.60 | -29.04 | -85.29 | -82.83 | - | - | - |
ROCE % |
-121.49 | -114.82 | -60.36 | -57.62 | -167.18 | 242.16 | -494.34 | -225.74 | -194.09 | 1283.50 | - | - | - |
Current Ratio |
8.0 | 12.3 | 14.8 | 9.4 | 3.8 | 0.5 | 1.8 | 3.0 | 1.5 | 1.0 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Relmada Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.72 | -0.59 | -0.72 | - | -0.73 | -0.84 | -0.87 | - | -1.31 | -1.33 | -1.4 | - | -2.44 | -1.56 | -1.34 | - | -1.05 | -0.73 | -0.72 | - | -0.38 | -0.5 | -0.38 | -0.28 | -1.08 | -0.55 | -0.27 | -0.11 | -0.08 | -0.11 | -0.16 | -0.09 | -0.14 | -0.09 | -0.15 | -0.22 | 0.43 | -0.22 | 0.43 | 0.55 | -3.66 | 0.11 | 1.98 | -2.1 | -0.64 | - | -0.03 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | - | - | -1.29 | -1.52 | -1.3 | - | -2.44 | -1.55 | -1.35 | - | -1.07 | -0.83 | -0.68 | - | -0.38 | -0.5 | -0.38 | -0.14 | -0.77 | -0.31 | -0.19 | -0.12 | -0.08 | -0.12 | -0.08 | -0.13 | -0.13 | -0.12 | -0.13 | -0.5 | -0.43 | -0.5 | -0.43 | -0.43 | -0.46 | -0.54 | -0.07 | -0.18 | -0.2 | - | - | - | - | - | - | - | - | - | - |
ROE % |
-126.65 | -102.88 | -96.71 | -65.55 | -89.25 | -91.10 | -88.66 | -62.87 | -121.49 | -156.41 | -163.54 | -110.40 | -126.41 | -83.81 | -66.92 | -36.65 | -39.82 | -26.98 | -20.02 | -9.91 | -506.83 | -739.26 | -1232.62 | -1190.78 | -891.78 | -723.20 | -424.20 | -529.90 | -354.02 | -316.43 | -133.15 | -89.42 | -88.28 | -25.15 | -38.44 | 37.79 | 177.49 | 287.78 | -176.23 | 2461.51 | 2371.51 | 13688.45 | 14242.21 | 11602.83 | 11574.28 | 83.22 | 13.09 | -38.19 | -39.34 | -10.11 | -1.82 | - | -0.91 | - | - |
ROA % |
-110.02 | -91.19 | -86.91 | -60.31 | -81.37 | -82.28 | -80.06 | -57.18 | -104.03 | -129.82 | -135.28 | -92.21 | -106.51 | -73.96 | -59.40 | -32.74 | -35.87 | -24.70 | -18.82 | -9.78 | -225.90 | -440.00 | -670.37 | -778.13 | -583.73 | -383.99 | -200.41 | -124.12 | -118.96 | -122.18 | -81.93 | -63.35 | -61.61 | -18.13 | -18.16 | 16.97 | 48.43 | -81.48 | -50.22 | -185.15 | -344.04 | -8059.47 | -8358.82 | -8359.87 | -8218.06 | -414.14 | -141.10 | -24.23 | -23.78 | -5.13 | - | - | - | - | - |
ROCE % |
-133.35 | -107.57 | -100.34 | -68.34 | -91.63 | -92.39 | -92.13 | -64.61 | -123.29 | -158.68 | -162.89 | -110.58 | -126.86 | -84.45 | -69.21 | -37.80 | -41.01 | -27.94 | -19.43 | -9.99 | -252.48 | -417.34 | -824.32 | -793.53 | -753.02 | -651.92 | -443.34 | -537.89 | -368.78 | -330.81 | -150.65 | -106.64 | -122.42 | -126.87 | -170.01 | -199.60 | -246.44 | -195.01 | 265.34 | 653.58 | 777.21 | 4287.39 | 3983.49 | 3699.09 | 3671.17 | 112.89 | -0.46 | -51.74 | -51.98 | -21.84 | - | - | - | - | - |
Current Ratio |
6.9 | - | 6.8 | 8.0 | - | - | 13.4 | 12.3 | - | - | 14.7 | 14.8 | - | - | - | 9.4 | - | - | - | 80.3 | 46.2 | 44.9 | 44.9 | 1.8 | 0.1 | 0.4 | 0.4 | 1.1 | 1.4 | 2.1 | 2.1 | 4.0 | 3.4 | 3.2 | 3.2 | 3.4 | 1.3 | 1.6 | 1.0 | 1.2 | 0.6 | 1.0 | 1.0 | 0.2 | - | - | - | 0.3 | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 64579.9 | 4286.8 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 61704.8 | 5790.7 | - | 9363.3 | 1099.9 | 6027.9 | 133.0 | 1093.1 | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 64579.9 | 4286.8 | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -61704.8 | -5790.7 | - | -9363.3 | -1099.9 | -6027.9 | -133.0 | 63486.8 | 4286.8 | - | - | - | - |
Все данные представлены в валюте USD